Navigation Links
China Pharma Holdings, Inc. Announces Record 2007 Year End Results
Date:3/31/2008

atements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as unanticipated changes in product demand, increased competition, failure to obtain or maintain intellectual property protection, downturns in the Chinese economy, uncompetitive levels of research and development, failure to obtain regulatory approvals, and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

CHINA PHARMA HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

December 31, December 31,

2007 2006

ASSETS

Current Assets:

Cash and cash equivalents $ 1,830,335 $ 656,441

Trade accounts receivable, less

allowance for doubtful

accounts of $2,440,852 and

$1,562,494, respectively 18,572,976 12,101,979

Other receivables, less allowance

for doubtful accounts of

$43,908 and $27,517,

respectively 496,313 355,554

Deferred offering costs -- 59,390

Advances to suppliers 3,481,948 2,255,877

Inventory
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., , SAN MATEO, Calif., Nov. 24 /PRNewsw..., a biopharmaceutical company focused on developin...ies, announced today that Anthony DiTonno, Preside...esent at the 21st Annual Piper Jaffray Health Care...New York Palace Hotel in New York, New York. ,...
(Date:11/24/2009)... The FBI recently approved...oratories participating in or generating DNA recor... Madison, WI USA (PRWEB) -- The FBI ...S System for use by laboratories participating in...Index System (NDIS). NDIS currently contains more ...
(Date:11/24/2009)..., , DUBLIN, November 24 /PRNewswire-Fi... the global specialty biopharmaceutical company, t...European Medicines Agency for,velaglucerase alfa, ...pment,for the treatment of Type 1 Gaucher disease....lucerase alfa that has been submitted, with previo...
(Date:11/24/2009)..., BOZEN,Italy,November24/PRNewswire/--HealthR...ointventurewithagroupofselected,investors.Thisrece...nameHealthRoboticsCanada,Inc.andwillmarket,install...ept,whichincludesthe,revolutionaryproductofferings...oticsCanadaInc.willalsoprovideassistanceonan"asnee...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
..., Aug. 19 Omeros Corporation, a,Seattle-based cli...h AS, a,Norwegian human antibody therapeutics comp...n agreement for the discovery and development of f...MASP-2, or mannan-binding,lectin-associated serine...,system via the lectin pathway and is linked to mu...
...olio of Transfusion Solutions Offers Choice, ...ROCKAWAY, N.J., Aug. 18 Biotest Diagnostics Corpo...based Biotest AG, a worldwide,supplier of traditio...s,that it has received final clearance from the U....keting its full line of traditional blood,bank rea...
... 4C Controls Inc. (OTCBB: FOUR.OB) today announc...(Ret.) Dr. Philip Hayden as its Vice President, Se... NEW YORK (Business Wire EON) A... after a distinguished career with the Federal Bur...years involved in many aspects of law enforcement ...
Other Biology Technology:Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 3Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents 2Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents 3 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 2 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 3 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 4
(Date:11/24/2009)...rs to understanding how sounds associated with Nav...l or if they hear it at all. , The same type of...ses to detect flaws in the space shuttle,s behemot... peek inside the giant head of a whale. The scans ...of a whale,s hearing anatomy using a breakthrough ...
(Date:11/24/2009)... of Medical Toxicology (ACMT) have signed an agree...rnal of Medical Toxicology (JMT), the official jo...s previously published by the University of Pennsy...ogy , an international, peer-reviewed journal, is ... medical toxicology. The quarterly journal focuse...
(Date:11/24/2009)...) New research on bacterial communities throughou...table temporal patterns, suggesting that scientist...oring climate change in the polar regions. The stu... National Academy of Sciences Early Edition, show...fted synchronously over time, correlating with sea...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 1New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 2New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 3New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 4New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 5New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 6Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Desig 57642 1Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Desig 57642 2Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Desig 57642 3AAA Members Save and Stay Healthy With Annual Eye Exams 57638 1AAA Members Save and Stay Healthy With Annual Eye Exams 57638 2AAA Members Save and Stay Healthy With Annual Eye Exams 57638 3
...Tulane National Primate Research Center has for th... agents in a vaginal gel protect the animals again... microbicide using compounds that inhibit the proc...ells could potentially provide a safe, effective a...men, according to study investigators. The study, ...
...anipulating the mosquitoes, sense of smell is the ...nderbilt University, that has been selected to rec...to Global Health. , The initiative, which was laun... just announced the selection of 43 "groundbreakin...ng countries that will receive a total of $436 mil...
...ty researchers have identified some of the key fac...d by multiple sclerosis (MS), complications of pre...he findings offer important clues about why the ne...ys that at least some forms of brain damage could ...st edition of the scientific journal Nature Medici...
Other Biology News:Vaginal gel may provide a new approach to HIV prevention 2Fighting malaria by manipulating mosquitoes' sense of smell 2Fighting malaria by manipulating mosquitoes' sense of smell 3Molecular Partners Required For Appropriate Neuronal Gene Repression 2Molecular Partners Required For Appropriate Neuronal Gene Repression 3Molecular Partners Required For Appropriate Neuronal Gene Repression 4
Z Amphetamine ELISA Kit, Single from Bio-Quant Inc.
Rat CGRP EIA Kit from Cayman Chemical
...RNA service provides the premium quality siRNAs yo...RNAs can be readily ordered online by providing ei...ng the sense and antisense siRNA sequences. (Also ... Pre-designed siRNAs, which are already designed f...
Custom siRNA, HPLC purified from Ambion
Biology Products: